Key result
TAVR resulted in zero 30-day mortality versus four deaths with SAVR (p=0.029) and significantly reduced operation time, blood use, and hospital stays in low- to intermediate-risk patients.
Authors
Loading...
Evaluating TAVR demonstrates favorable outcomes in low- to intermediate-risk aortic regurgitation patients, suggesting potential advantages over surgery.
Zhang et al. (2026) studied this question. TAVR resulted in zero 30-day mortality versus four deaths with SAVR (p=0.029) and significantly reduced operation time, blood use, and hospital stays in low- to intermediate-risk patients.
Synapse has enriched one closely related paper. Consider it for comparative context: